Champions Oncology, Inc. offers technology solutions that personalize the development and use of oncology drugs. The company’s Tumorgraft Technology Platform is an approach to personalizing cancer care based upon the implantation of human tumors in immune-deficient mice. Through this platform, the company provides Personalized Oncology Solutions that assist physicians in developing customized treatment options for their cancer patients through tumor-specific data obtained from drug studies and related personalized oncology services. For more information, visit the company’s website at www.championsoncology.com.